Cannabis from seed to market
High quality products
Natural medical solutions

About
UNIVO Pharmaceuticals

UNIVO Pharmaceuticals is a vertically-integrated medical cannabis company covering all aspects of cultivation, manufacturing and distribution, Our highly experienced researchers holding PhDs in chemistry, analytical chemistry, biomedicine and pharmaceuticals come together to create innovative and dosage formed products for next-generation medical cannabis.

UNIVO possess initial licenses for the entire supply chain:

  • Growing, breeding and nursery
  • Production of medical cannabis products
  • Research and development
  • Distribution

Mission
Statement

To help patients worldwide with all natural Cannabis based solutions that treat a wide variety of indications with superior efficacy, improved safety and fewer side effects compared to currently available treatment.

UNIVO Vision:-To become a leading multinational Medical Cannabis company that develops, grows, manufactures and distributes Medical Cannabis products worldwide using our highly developed technologies, expertise and supply chain.

 

 

The UNIVO Advantage

Univo offers a complete single point solution to medical cannabis, from seed to market.

Quality

Production takes place in our IMC-GMP approved facility and meets the regulatory guidelines of the Israeli Ministry of Health. All UNIVO products undergo rigorous laboratory testing to ensure both quality and regulatory compliance are up to GMP standard before leaving the factory for distribution to our customers and patients.

Extraction Technologies

The production facility is equipped with cutting edge Ethanol and CO2 extraction technologies. The different properties of each extracting material enable optimal extraction of various substances from the plant in addition to the active ingredients CBD, THC.  This “Entourage Effect” enhances the effect of the active ingredients.

Proprietary Extraction

The production facility is equipped with cutting edge Ethanol and CO2 extraction technologies. The different properties of each extracting material enable optimal extraction of various substances from the plant in addition to the active ingredients CBD, THC.  This “Entourage Effect” enhances the effect of the active ingredients.

What makes UNIVO special

  • Specialization in high quality unique genetics for medical use
  • R&D laboratory on-site
  • Production of medical grade cannabis-based products
  • Distribution and exportation to international markets

UNIVO Factory

  • 750m² factory area
  • CO2 and Ethanol extraction methods
  • Compliant with GMP standards
  • R&D laboratory on-site

The
Process

UNIVO

  • Experienced R&D team
  • 100m2 laboratory
  • Pipeline of IP protected products in development
  • R&D collaboration agreements with technology companies and hospitals
  • Establishing fully GAP/GMP compliant farm in partnership with the Amit Farm
  • Agreements in place to import seeds and mix breed our own genetics
  • Completely computerized, 14,000m2 greenhouse in full compliance with GAP standards and equipped with industry leading environmental control system
  • GMP Certified
  • Facility area (1300m2), Q2 2019
  • CO2 & Ethanol extraction methods
  • Plants, oil, cream, wax and more Compliant with GMP standards
  • The Israeli market
  • Pharmacies
  • The global market-planned partnerships in Europe, Canada and worldwide

11/11/2019

Can-Fite Obtains Patent For Treatment Of Osteoarthritis In Mammals

31/10/2019

Cannabis co Univo raises NIS 12m from Avisror Group

29/10/2019

Univo medical cannabis approved for pharmacy sales

10/09/2019

Can-Fite Partners, Univo Pharmaceuticals Join Forces On Medical Cannabis-Based Therapeutics

19/07/2019

Export Go-Ahead Will Fire-Up Israeli Company

UNIVO Farm

Havat Amit LTD

UNIVO has acquired 74% in the Amit Farm, a family business with decades of successful agricultural experience located in Southern Israel. The farm spans over 75,000m² of which 15,000 m² is designated for cannabis growth. Amit Farm is authorized to build a cannabis growth farm for medical purposes under IMC-GAP regulations.

The farm enables us to cultivate and breed unique cannabis strains which are targeted to meet specific medical needs. A portion of the farm is allocated for use by start-up companies who are attempting to develop their own strains but lack the agricultural capabilities, resources and or expertise.

Estimated time for finalizing construction is Dec 2019, planting will start on Jan 2020.  

Leading Israels Medical Cannabis Industry:- UNIVO is positioned as a leader in the Israeli market for medical cannabis, by combining our manufacturing facility with an estimated 9,250m² of greenhouse area and 500m² drying facility in Havat Amit LTD.

Leading Israels Medical Cannabis Industry

UNIVO will be positioned as a leader in the Israeli market for medical cannabis, by combining our manufacturing facility with an estimated 9,250m² of greenhouse area and 500m² drying facility in Havat Amit LTD. 

Phase I

9,250

square meters

GREENHOUSE AREA

In Progress

Phase II

500

square meters

DRYING
FACILITY

In Progress

Phase III

14,750

square meters

PRODUCTION EXPANSION

Pending

Phase IV

51,525

square meters

PRODUCTION EXPANSION

Pending

Expansion Plan

12,500

square meters

CURRENTLY AUTHORIZED AREA

In Progress